Results 111 to 120 of about 180,590 (201)

Human Leucocyte Antigen‐G (HLA‐G) and Its Murine Functional Homolog Qa2 in the Trypanosoma cruzi Infection [PDF]

, 2015
Fabrício C. Dias, Celso Teixeira Mendes‐Junior, Maria Cláudia Silva, Fabrine Sales Massafera Tristão, Renata Dellalibera-Joviliano, Philippe Moreau, Edson García Soares, Jean G. Menezes, André Schmidt, Roberto Oliveira Dantas, José Antônio Marin‐Neto, João S. Silva, Eduardo Antônio Donadi   +12 more
openalex   +1 more source

Identification of a novel HLA-G allele, HLA-G*01:66, using PolyseqOne and oxford nanopore sequencing. [PDF]

Front Genet
Li R, Sun L, Cai S.
europepmc   +1 more source

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma [PDF]

, 2017
Bianchi, Maurizio, Buffardi, Salvatore, Burnelli, Roberta, Caggiari, Laura, Carosella, Edgardo D., D'Amore, Emanuele Stefano, DE ZORZI, Mariangela, Elia, Caterina, Famengo, Barbara, Farruggia, Piero, Martina, Lia, Mascarin, Maurizio, Muggeo, Paola, Mussolin, Lara, Pillon, Marta, Re, Valli, Sala, Alessandra, Santoro, Nicola, Vinti, Luciana   +18 more
core   +1 more source

Harnessing the immunomodulatory properties of HLA-G for advanced immunotherapies. [PDF]

Front Immunol
Beli X, Savvopoulos N, Kefala D, Lysandrou M, Liga M, Spyridonidis A.   +5 more
europepmc   +1 more source

Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathway. [PDF]

J Immunother Cancer
Beers C, Ilaria RL, Luke JJ.
europepmc   +1 more source

The effects of mesenchymal stem cells on the IDO, HLA-G and PD-L1 expression of breast tumor cells MDA-MB-231 and MCF-7

, 2019
Rabia Bilge Özgül Özdemir, Alper Tunga Özdemir, Cengiz Kırmaz, Mehmet İbrahim Tuğlu, Özgür Şenol, Cenk Serhan Özverel, Afig Berdelı   +6 more
openalex   +2 more sources

Editorial: HLA-G in health and disease: comprehensive insights and future therapeutic directions. [PDF]

Front Immunol
Russick J, Rizzo R, Ajith A.
europepmc   +1 more source

Soluble HLA-G is related to malignant melanocytic lesions and previous oncological disease may increase circulating HLA-G bearing large extracellular vesicles. [PDF]

Front Immunol
Silva-Krebs KK, de Oliveira EM, Athayde CA, da Fonseca PB, De Felice FG, Carvalho FR, Sá Araújo M, Luz FB, Silva AA, Pantaleão L, Medeiros T, Dayse-Silva IL.   +11 more
europepmc   +1 more source

HLA-J, A SECOND INACTIVATED CLASS I HLA GENE RELATED TO HLA-G AND HLA-A [PDF]

, 1992
Girdlestone, J., Messer, Gerald, Orr, Harry T., Parham, P., Weiss, Elisabeth H., Zemmour, Jaqueline   +5 more
core   +1 more source

HLA-G, IL-6 and TGF-β in Seminal Plasma as Potential Biomarkers of ART Outcome. [PDF]

Am J Reprod Immunol
Schallmoser A, Emrich N, Masslow L, Allam JP, Einenkel R, Sänger N.   +5 more
europepmc   +1 more source